CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Condensed Consolidated Statements Of Operations
Revenues
Operating Expenses
Research and development	$ 829,156	$ 477,123
General and administrative	294,221	293,018
Stock-based compensation - general and administrative	121,299	108,764
Total Operating Expenses	1,244,676	878,905
Operating Loss	(1,244,676)	(878,905)
Other Income (Expense), Net:
Interest income	15	2,208
Gain on revaluation of derivative warrant liability	$ 23,940	60,489
Interest expense		(7,500)
Total Other Income (Expense), Net	$ 23,955	55,197
Loss before Income Taxes	$ (1,220,721)	$ (823,708)
Income tax benefit
Net Loss	$ (1,220,721)	$ (823,708)
Net Loss Per Share - Basic and Diluted	$ (0.04)	$ (0.03)
Weighted Average Common Shares Outstanding Basic and diluted	34,414,988	30,036,759